General (Ret.) James T. Hill SEC EDGAR Filings (CIK 0001441718)

SEC EDGAR filings, ownership reports, and insider transactions for General (Ret.) James T. Hill.

Business address
C/O Ibiopharma, Inc., 9 Innovation Way, Suite 100, Newark, DE, 19711
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
General (Ret.) James T. Hill has filed 12 SEC EDGAR filings since 12 Aug 2008

Latest Filings

Recent SEC filings for General (Ret.) James T. Hill including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 13 Dec 2021 09 Dec 2021 001-35023
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 31 May 2019 01 Apr 2019 001-35023
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 13 May 2019 20 Feb 2019 001-35023
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 16 Jun 2017 01 May 2017 001-35023
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 05 Apr 2017 05 Sep 2014 001-35023
4 Open 4 document View SEC filing for 4 05 Aug 2013 15 Jul 2013 001-35023
4 Open 4 document View SEC filing for 4 FORM 4 26 Jul 2012 24 Jul 2012 001-35023
4 Open 4 document View SEC filing for 4 FORM 4 31 Oct 2011 21 Oct 2011 001-35023
4 Open 4 document View SEC filing for 4 FORM 4 09 Sep 2010 16 Aug 2010 000-53125

About this filer

General (Ret.) James T. Hill files with the SEC under CIK 0001441718. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages